Health
Sinopharm vaccine for COVID-19 elicits immunity to South Africa variant, but with minor effect – Explica
BEIJING, Feb 3 (.) – Two COVID-19 vaccines from Chinese companies, including Sinopharm, elicited immunity against a highly communicable variant of the coronavirus…
BEIJING, Feb 3 (.) – Two COVID-19 vaccines from Chinese companies, including Sinopharm, elicited immunity against a highly communicable variant of the coronavirus first found in South Africa, but its effect appeared to be weaker, a study showed laboratory with small samples.
Variants of the virus have raised concerns that they may weaken the effects of vaccines and treatments developed before their emergence.
Twelve serum samples taken from recipients of two vaccines developed by a Sinopharm subsidiary…
-
General22 hours agoRussia launches hundreds of drones and missiles against Ukraine in fresh attack
-
Business15 hours agoWhy did this ASX 200 healthcare stock crash 14% yesterday?
-
Business17 hours agoOwn Xero shares? Here are 3 key takeaways from its AGM
-
Business14 hours agoHere’s what analysts expect for the BHP share price in the coming year